The Make-or-Break Moment for Payers in Specialty Care Our chief strategy officer speaks with Becker's about the largely untapped potential of value-based specialty care. Read Article
Bending the Oncology Cost Curve in 2023 and Beyond Our chief medical officer shares three trends likely to impact oncology drug spend in the near future. Read Article
